drugset / Trial / NCT05897307

Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve Block

NCT05897307 ↗

Unknown 90 enrolled Fayoum University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Background: Multimodal analgesia for control of postoperative pain in cardiac surgical patients helps in early recovery and ambulation. Pectoral nerve (PECS) block with ropivacaine is novel, less invasive regional analgesic technique with an effect comparable to paravertebral, and thoracic epidural analgesia. Aim: The aim of this study is to assess the effect of dexmedetomidine as an adjuvant to ropivacaine on the quality and efficiency of the ultra-sound guided pectoralis nerve block in patients undergoing open heart surgery through midline sternotomy for fast-track anesthesia and postoperative analgesia.

Timeline

Start
2023-08-01
Primary completion
2024-08-10
Completion
2024-08-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Other
Comparator Ropivacaine Other / unclassified 0.25 % Other
Comparator Ropivacaine Other / unclassified 30 ml Other

Indications

No indication recorded.